image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates and Ideas

N4Pharma - Reformulated Viagra planned for 2019 launch

May 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • N4P
  • Price:
  • 20.5p
At a much earlier stage of development than Alliance Pharma, which features on page 3, and only for those who want a total speculation, is N4 Pharma (N4P; 20.5p). During the month I met with chief executive Nigel Theobald who established the business in 2014. It joined AIM in May last year following a reverse into an existing cash shell; it wanted to raise £3m but broker Beaufort only succeeded in getting £1.5m and to get the issue away also attached warrants to the shares (1 for 1 and exercisable at 8.5p by next May).N4 has therefore been propelling itself on a shoestring with only six staff (including the four board directors!) with everything else outsourced. But for the warrants, half of which have been exercised, g ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW